Published briefing
FDA Accepts Cogent's Bezuclastinib NDA for AdvSM
The FDA accepted Cogent Biosciences' NDA for bezuclastinib in AdvSM, with a PDUFA target action date of June 29, 2027.
PipDig Newsroom ·
Read briefingMarket News
The following Forex news reports are the latest developments of the Forex market. The news reports are updated frequently and include all the events that affect the foreign exchange trading industry.
More briefings
Published briefing
Tallink Grupp Issues New Shares via Option Exercise
AS Tallink Grupp issued 5,216,300 new ordinary shares after option holders exercised rights, lifting total shares to 748,785,364.
Read briefingPublished briefing
eQ Plc Board Sets Dividend Payment Dates
eQ Plc's board on 15 September 2026 set 7 October 2026 as the record date and 14 October 2026 as the payment date for its second dividend instalment.
Read briefingPublished briefing
Festi Completes FESTI270322 Bill Issuance
Festi hf. completed a six-month bill issuance, FESTI270322, settling Tuesday, 22 September 2026, with Íslandsbanki managing the sale.
Read briefing
Published briefing
Star Bulk Completes $124.42M Share Allocation
Star Bulk Carriers completed its share allocation on Friday, 11 September 2026, raising $124.42 million at $28.27 per share.
Read briefingPublished briefing
FWMOH Opens New Decatur Clinic, Shuts Bluffton
Fort Wayne Medical Oncology and Hematology opens a new Decatur clinic Sept. 23, 2026, consolidating its Bluffton site by Sept. 29, 2026.
Read briefing
Published briefing
Djurslands Bank Prices Tier 2 Capital Issue
Djurslands Bank A/S issues Tier 2 supplementary capital, maturing September 2036 with a September 2031 call option.
Read briefing
Published briefing
Arteris Expands Multi-Die Portfolio With FlexGen
Arteris expands its multi-die portfolio with a new FlexGen Multi-Die product, the Campbell, Calif.-based company said Sep 15, 2026.
Read briefing
Published briefing
Ziggo Group Targets Euronext Amsterdam Listing by Mid-2027
Ziggo Group, formed from VodafoneZiggo and Telenet, targets a mid-2027 listing on Euronext Amsterdam.
Read briefing